These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5667860)

  • 1. Enzyme alterable alkylating agents. X. Experimental study of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Ulfohn A; Kramer SP; Calle S; Sass S; Williamson CE; Witten B; Seligman AM
    J Surg Res; 1968 Aug; 8(8):345-59. PubMed ID: 5667860
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme alterable alkylating agents. XI. Clinical trials of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Bakal D; Goodman LE; Ulfohn A; Mamaril AG; Caplan YH; Calle S; Bhagavan BS; Witten B; Williamson CE; Sass S; Seligman AM
    J Surg Res; 1971 May; 11(5):217-23. PubMed ID: 5090338
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary study of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Goodman LE; Ulfohn A; Kramer SP; Calle S; Bakal D; Madamba R; Witten B; Williamson CE; Sass S; Seligman AM
    Cancer; 1967 May; 20(5):826-8. PubMed ID: 6024292
    [No Abstract]   [Full Text] [Related]  

  • 4. RESULTS OF REGIONAL CHEMOTHERAPY OF NEOPLASMS OF THE UPPER BODY BY TEMPORARY MID-TORSO VASCULAR OCCLUSION.
    CLAPP P; TAYAO MS; MILLER DG; LAWRENCE W
    Cancer; 1964 Aug; 17():1012-25. PubMed ID: 14202589
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparison of intravenous and intra-arterial nitrogen mustard after the arterial injection of tumor cells.
    ROBINSON KP; HOPPE ET
    Cancer; 1963 Mar; 16():350-4. PubMed ID: 13974454
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrogen mustard hydrochloride.
    Rep Carcinog; 2004; 11():III192-3. PubMed ID: 21105251
    [No Abstract]   [Full Text] [Related]  

  • 7. SYSTEMIC THIOSULFATE PROTECTION DURING FRACTIONATED REGIONAL NITROGEN MUSTARD THERAPY.
    LAWRENCE W; TAYAO MS; MAHAJAN RD; PAGE R; MILLER DG; CLAPP P
    J Surg Res; 1964 Nov; 4():483-94. PubMed ID: 14224011
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential perfusion hypothermia. It's use in selective bone marrow protection during the administration of nitrogen mustard.
    LEE JM; LESAGE AM; SEALY WC; YOUNG WG
    JAMA; 1962 Feb; 179():435-6. PubMed ID: 14463516
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of reserpine on the lethal effect of cytotoxic alkylating agents.
    Yamamoto I; Kimura H; Iwatsubo K
    Jpn J Pharmacol; 1968 Mar; 18(1):39-47. PubMed ID: 5302459
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow protection as a potential aid to chemotherapy.
    AMBRUS CM; BACK N; AMBRUS JL
    Acta Unio Int Contra Cancrum; 1960; 16():540-1. PubMed ID: 13793133
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.
    MILLER DG; LAWRENCE W
    Arch Surg; 1962 Sep; 85():430-41. PubMed ID: 14473972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the side effects of embikhin, sarcolysin and asalin].
    Sof'ina ZP
    Farmakol Toksikol; 1969; 32(3):312-6. PubMed ID: 5810949
    [No Abstract]   [Full Text] [Related]  

  • 14. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective action of autologous marrow against nitrogen mustard toxicity.
    BLACK MM; SPEER FD; STONE ML
    Ann Intern Med; 1959 Sep; 51():517-25. PubMed ID: 13801160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nitrogen mustard perfusion on the cellular elements of the blood and bone marrow].
    Barczyński M
    Pol Tyg Lek; 1966 Oct; 21(41):1560-3. PubMed ID: 5980358
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative characteristics of the toxicity and antitumor activity of a number of haloid derivatives of embikhin and Nor HN2].
    Demirchoglian IG; Babasian OV; Galstian DA
    Zh Eksp Klin Med; 1979; 19(5):46-52. PubMed ID: 525103
    [No Abstract]   [Full Text] [Related]  

  • 18. [PROLONGED INTRA-ARTERIAL CHEMOTHERAPY USING AN ANTINEOPLASTIC INFUSION IN THE TREATMENT OF INOPERABLE NEOPLASIA. 1. INTRODUCTION, MATERIAL AND METHOD].
    ESTEVEZ RA
    Sem Med; 1963 Sep; 123():851-61. PubMed ID: 14093417
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatal panmyelopathy under combined therapy with roentgen rays and nitrogen mustard (mitomem)].
    KIRCHMAIR H
    Wien Klin Wochenschr; 1960 Apr; 72():281-4. PubMed ID: 14409301
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies in isolated perfusion chemotherapy. I. Nitrogen mustard.
    AUSMAN RK; AUST JB
    Ann Surg; 1961 Apr; 153(4):527-32. PubMed ID: 13685189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.